Alzheimer's drug design based upon an invertebrate toxin (anabaseine) which is a potent nicotinic receptor agonist (Q48369775)
scientific article published in September 1997
Language:
(P31) (Q13442814)
(P304) 251-259
(P433) 2-3
(P478) 3
(P577) Monday, September 1, 1997
(P921) (Q11081)
(P1433) (Q15765140)
(P1476) "Alzheimer's drug design based upon an invertebrate toxin (anabaseine) which is a potent nicotinic receptor agonist" (language: en)
(P2093) W R Kem
(P2860) (Q48871689)
(Q34670673)
(Q54385550)
(Q52563684)
(Q41347185)
(Q48687532)
(Q28592111)
(Q72518268)
(Q69421805)
(Q44626908)
(Q28594028)
(Q43715001)
(Q34729107)
(Q52053777)
(Q48354475)
(Q48123866)
(Q48478838)
(Q34449461)
(Q49072058)
(Q48117680)
(P13046) (Q7318358)
other details
description scientific article published in September 1997

External Links